QuantX Biosciences
Latest round
- Series B
Last raised
- Feb 2026
Total raised
- $85M
Investors
- 5
About QuantX Biosciences
QuantX Biosciences, Inc.Founded in 2022, QuantX Biosciences, Inc. operates out of Princeton, US, and specializes in drug discovery within the biopharmaceutical sector.QuantX specializes in the discovery and development of innovative oral small molecule therapeutics, targeting validated areas in immunology and inflammation. Utilizing a proprietary computational platform, the company enhances the discovery process for superior drug candidates, allowing for significant optimization of these compounds. Their main product offerings focus on a pipeline of oral small molecules designed to address clinically validated therapeutic targets, catering to healthcare providers and pharmaceutical partners involved in treating inflammatory and immunological conditions. Specific pricing plans for their services are aligned with the complexity and scope of the projects undertaken, which may involve both upfront payments and success-based fees depending on the achievement of agreed-upon milestones.In February 2026, QuantX Biosciences, Inc. The company plans to launch new products focused on these therapeutic areas and expand its presence in both North American and European markets.
Who invested in QuantX Biosciences
5 investors across 2 rounds
See all investors in QuantX Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about QuantX Biosciences
Who invested in QuantX Biosciences?
QuantX Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has QuantX Biosciences raised?
QuantX Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did QuantX Biosciences last raise money?
QuantX Biosciences's most recent round on record is a Series B, in Feb 2026.
What does QuantX Biosciences do?
QuantX Biosciences is a biotechnology company.
Where is QuantX Biosciences headquartered?
QuantX Biosciences is headquartered in Princeton, US.
Which VCs invest in companies like QuantX Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at QuantX Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like QuantX Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.